Skip to main content
. 2024 Mar 28;16(4):472. doi: 10.3390/pharmaceutics16040472

Figure 1.

Figure 1

Melting point distribution of 24 APIs formulated as ASDs in currently marketed drug products (adapted from Alzahrani et al. [19]).